EICHOR
● Completed
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites
Condition: Influenza, Human · Respiratory Syncytial Virus Infections · Sponsor: LumiraDx UK Limited
About this study
A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx Influenza A/B + RSV Test at Point of Care Testing Sites
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (20)
| MedHelp Urgent Care | Birmingham, Alabama, United States | — |
| Access Medical Center | Encinitas, California, United States | — |
| Madera Family Medical Group | Madera, California, United States | — |
| ImmunoE Health and Research | Centennial, Colorado, United States | — |
| Complete Family Care Research | Northglenn, Colorado, United States | — |
| ImmunoE Health and Research Center | Thornton, Colorado, United States | — |
| Accel-West Volusia Pediatrics | DeLand, Florida, United States | — |
| Nona Pediatric Center | Orlando, Florida, United States | — |
| New Medical | Wichita, Kansas, United States | — |
| Gvozden Pediatrics | Millersville, Maryland, United States | — |
| Kent Plaza Pediatrics | Jackson, New Jersey, United States | — |
| Jersey Shore UMC | Neptune City, New Jersey, United States | — |
+ 8 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04288921